Xavier Bosch

Summary

Affiliation: Universitat de Barcelona
Country: Spain

Publications

  1. ncbi request reprint Antineutrophil cytoplasmic antibodies
    Xavier Bosch
    Department of Internal Medicine, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, University of Barcelona, Barcelona, Spain
    Lancet 368:404-18. 2006
  2. doi request reprint Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted t
    Xavier Bosch
    Cardiology Department, Thorax Institute, Hospital Clinic, Barcelona, Spain
    J Am Coll Cardiol 61:2355-62. 2013
  3. ncbi request reprint Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome
    Pilar Brito-Zeron
    Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain
    Clin Exp Rheumatol 31:103-10. 2013
  4. ncbi request reprint Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome
    Soledad Retamozo
    Department Autoimmune Diseases, Hospital Clinic, Barcelona, Spain
    Clin Exp Rheumatol 30:686-92. 2012
  5. doi request reprint Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes
    Pilar Brito-Zeron
    Sjögren Syndrome Research Group AGAUR, Laboratory of Autoimmune Diseases Josep Font, Institut d Investigacions Biomediques August Pi i Sunyer, Department of Autoimmune Diseases, ICMiD, Hospital Clinic, Barcelona, Spain
    J Autoimmun 39:43-8. 2012
  6. ncbi request reprint Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes
    Xavier Bosch
    Department of Cardiology, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Villarroel 170, Barcelona, Spain, 08036
    Cochrane Database Syst Rev 11:CD002130. 2013
  7. doi request reprint B-cell depleting agents for ANCA vasculitides: a new therapeutic approach
    José A Gómez-Puerta
    Department of Rheumatology, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, University of Barcelona, Barcelona, Spain
    Autoimmun Rev 11:646-52. 2012
  8. pmc Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study
    José T Ortiz-Pérez
    Thorax Institute, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    PLoS ONE 8:e61695. 2013
  9. doi request reprint Comparison of quick diagnosis units and conventional hospitalization for the diagnosis of cancer in Spain: a descriptive cohort study
    Xavier Bosch
    Department of Internal Medicine, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    Oncology 83:283-91. 2012
  10. doi request reprint Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases
    Roberto Perez-Alvarez
    Laboratory of Autoimmune Diseases Josep Font, IDIBAPS, Department of Autoimmune Diseases, ICMiD, and Liver Unit, CIBERehd, Hospital Clinic, Barcelona, Spain
    Medicine (Baltimore) 90:359-71. 2011

Collaborators

Detail Information

Publications50

  1. ncbi request reprint Antineutrophil cytoplasmic antibodies
    Xavier Bosch
    Department of Internal Medicine, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, University of Barcelona, Barcelona, Spain
    Lancet 368:404-18. 2006
    ..Accurate understanding of the key pathogenic points of ANCA-associated vasculitis can undoubtedly provide a more rational therapeutic approach...
  2. doi request reprint Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted t
    Xavier Bosch
    Cardiology Department, Thorax Institute, Hospital Clinic, Barcelona, Spain
    J Am Coll Cardiol 61:2355-62. 2013
    ..This study sought to evaluate the efficacy of enalapril and carvedilol to prevent chemotherapy-induced left ventricular systolic dysfunction (LVSD) in patients with hematological malignancies...
  3. ncbi request reprint Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome
    Pilar Brito-Zeron
    Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain
    Clin Exp Rheumatol 31:103-10. 2013
    ....
  4. ncbi request reprint Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome
    Soledad Retamozo
    Department Autoimmune Diseases, Hospital Clinic, Barcelona, Spain
    Clin Exp Rheumatol 30:686-92. 2012
    ..To evaluate how determination of antibodies against the Ro52 antigen influences the classification and clinical characterisation of patients with suspected primary Sjögren's syndrome (SS)...
  5. doi request reprint Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes
    Pilar Brito-Zeron
    Sjögren Syndrome Research Group AGAUR, Laboratory of Autoimmune Diseases Josep Font, Institut d Investigacions Biomediques August Pi i Sunyer, Department of Autoimmune Diseases, ICMiD, Hospital Clinic, Barcelona, Spain
    J Autoimmun 39:43-8. 2012
    ....
  6. ncbi request reprint Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes
    Xavier Bosch
    Department of Cardiology, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Villarroel 170, Barcelona, Spain, 08036
    Cochrane Database Syst Rev 11:CD002130. 2013
    ..Glycoprotein IIb/IIIa blockers strongly inhibit platelet aggregation and may prevent mortality and myocardial infarction. This is an update of a Cochrane review first published in 2001, and previously updated in 2007 and 2010...
  7. doi request reprint B-cell depleting agents for ANCA vasculitides: a new therapeutic approach
    José A Gómez-Puerta
    Department of Rheumatology, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, University of Barcelona, Barcelona, Spain
    Autoimmun Rev 11:646-52. 2012
    ..However, issues regarding the use of maintenance therapy after rituximab, the concurrent use of cyclophosphamide and the toxicity of rituximab remain unanswered and should be clarified in ongoing and future randomized controlled trials...
  8. pmc Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study
    José T Ortiz-Pérez
    Thorax Institute, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    PLoS ONE 8:e61695. 2013
    ..3 to 15.2, p = 0.027). In conclusion, serum sACE2 activity rises in relation to infarct size, left ventricular systolic dysfunction and is associated with the occurrence of left ventricular remodeling...
  9. doi request reprint Comparison of quick diagnosis units and conventional hospitalization for the diagnosis of cancer in Spain: a descriptive cohort study
    Xavier Bosch
    Department of Internal Medicine, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    Oncology 83:283-91. 2012
    ..We compared the value and cost of a QDU and of conventional hospitalization in assessing patients with cancer...
  10. doi request reprint Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases
    Roberto Perez-Alvarez
    Laboratory of Autoimmune Diseases Josep Font, IDIBAPS, Department of Autoimmune Diseases, ICMiD, and Liver Unit, CIBERehd, Hospital Clinic, Barcelona, Spain
    Medicine (Baltimore) 90:359-71. 2011
    ..The increasing number of reported cases of HBV reactivation following TNF-targeted therapies and the associated morbidity and mortality demand specific preventive strategies...
  11. doi request reprint Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo?
    Xavier Bosch
    Department of Internal Medicine, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    Trends Immunol 29:280-9. 2008
    ..Therefore, an unmet need for safer and more effective therapies has prompted interest in biological agents. Continuous advances in the knowledge of AAV pathogenesis are paving the way to new biologicals that are now awaiting testing...
  12. ncbi request reprint Cryoglobulinemic disease
    Soledad Retamozo
    Laboratory of Autoimmune Diseases Josep Font, Department of Autoimmune Diseases, CELLEX, Institut d Investigacions Biomediques August Pi i Sunyer, Hospital Clinic, Barcelona, Spain
    Oncology (Williston Park) 27:1098-1105, 1110-6. 2013
    ..hyperviscosity), and the severity of internal organ involvement...
  13. doi request reprint Quick diagnosis units or conventional hospitalisation for the diagnostic evaluation of severe anaemia: a paradigm shift in public health systems?
    Xavier Bosch
    Department of Internal Medicine, Hospital Clinic, Institut d Investigacio Biomedica August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    Eur J Intern Med 23:159-64. 2012
    ..Anaemia with haemoglobin levels below 8 g/l has traditionally been a criterion used to hospitalise patients in our centre for diagnosis...
  14. doi request reprint Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases
    Roberto Perez-Alvarez
    Department of Internal Medicine, Hospital do Meixoeiro, Vigo, Spain
    Semin Arthritis Rheum 41:256-64. 2011
    ..To analyze the clinical characteristics, outcomes, and patterns of association with the different biologic agents used in all reported cases of adult patients developing interstitial lung disease (ILD) after biologic therapy...
  15. doi request reprint Pulmonary disorders induced by monoclonal antibodies in patients with rheumatologic autoimmune diseases
    Manuel Ramos-Casals
    Department of Autoimmune Diseases, Laboratory of Autoimmune Diseases Josep Font, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Spain
    Am J Med 124:386-94. 2011
    ..Large, prospective, postmarketing studies including nonbiological agents as controls may help elucidate the real risk of pulmonary disease in patients with rheumatologic autoimmune diseases receiving monoclonal antibodies...
  16. ncbi request reprint Adult haemophagocytic syndrome
    Manuel Ramos-Casals
    Josep Font Laboratory of Autoimmune Diseases CELLEX, Department of Autoimmune Diseases, Institut Clinic de Medicina i Dermatologia, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, University of Barcelona, Barcelona, Spain
    Lancet 383:1503-16. 2014
    ..Insufficient knowledge of these syndromes could contribute to poor prognosis. Early diagnosis is essential to initiate appropriate treatment and improve the quality of life and survival of patients with this challenging disorder...
  17. doi request reprint Aspiration pneumonia in old patients with dementia. Prognostic factors of mortality
    Xavier Bosch
    Department of Internal Medicine, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    Eur J Intern Med 23:720-6. 2012
    ..Prognostic factors of mortality in elderly patients with dementia with aspiration pneumonia (AP) are scarcely known. We determined the mortality rate and prognostic factors in old patients with dementia hospitalized due to AP...
  18. doi request reprint Quick diagnosis units: avoiding referrals from primary care to the ED and hospitalizations
    Xavier Bosch
    Department of Internal Medicine, Hospital Clinic, Institut d Investigacio Biomedica August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain
    Am J Emerg Med 31:114-23. 2013
    ..The aim of the present study was to determine whether quick diagnosis units (QDUs) can safely and efficiently avoid emergency department (ED) visits and hospitalizations...
  19. doi request reprint Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention
    Xavier Freixa
    Interventional Cardiology Section, Cardiology Department, Thorax Institute, Hospital Clinic, University of Barcelona, Villarroel 170, Barcelona 08036, Catalonia, Spain
    Eur Heart J 33:103-12. 2012
    ..Previous studies have shown that p-cond during primary percutaneous coronary intervention (PCI) confers protection against ischaemia-reperfusion injury and thus might reduce myocardial infarct size...
  20. pmc Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update
    José A Gómez-Puerta
    Department of Internal Medicine, Hospital Clinic, Barcelona, Spain
    Am J Pathol 175:1790-8. 2009
    ..Understanding the key pathogenic mechanisms of AAV may provide a safer, more rational therapeutic approach than the traditional (ie, corticosteroids and immunosuppressants) treatment strategy...
  21. ncbi request reprint Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease
    José A Gómez-Puerta
    Departments of Rheumatology, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    Chest 136:1101-11. 2009
    ..Thus, biological agents are emerging as potential therapies in refractory cases. Notably, rituximab and infliximab have been trialed with apparent initial clinical success...
  22. ncbi request reprint Additional value of B-type natriuretic peptide on discrimination of patients at risk for mortality after a non-ST-segment elevation acute coronary syndrome
    Ana García-Alvarez
    University of Barcelona, Barcelona, Spain
    Eur Heart J Acute Cardiovasc Care 3:132-40. 2014
    ..We aimed to evaluate whether BNP levels provide additional improvement on discrimination and reclassification of patients at risk of mortality during admission and follow up after a NSTE-ACS...
  23. doi request reprint Should alternatives to conventional hospitalisation be promoted in an era of financial constraint?
    Juan M Pericas
    Department of Internal Medicine, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    Eur J Clin Invest 43:602-15. 2013
    ..This review aims to present the available evidence on alternatives to conventional hospitalisation for medical disorders; options for surgery, psychiatry and palliative care are largely excluded...
  24. doi request reprint Topical and systemic medications for the treatment of primary Sjögren's syndrome
    Manuel Ramos-Casals
    Sjögren s Syndrome Research Group AGAUR, Laboratory of Autoimmune Diseases Josep Font, Department of Autoimmune Diseases, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Hospital Clinic, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain
    Nat Rev Rheumatol 8:399-411. 2012
    ..On the basis of this evidence, we provide guidance on the use of these agents in different clinical scenarios...
  25. doi request reprint The cryoglobulinaemias
    Manuel Ramos-Casals
    Josep Font Laboratory of Autoimmune Diseases, Institut Clinic de Medicina i Dermatologia, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    Lancet 379:348-60. 2012
    ..Studies suggest that both combined or sequential antiviral therapies and targeted biological treatments might be more effective than monotherapy...
  26. doi request reprint Vasculitis syndromes: LAMP-2 illuminates pathogenesis of ANCA glomerulonephritis
    Xavier Bosch
    Department of Internal Medicine, Hospital Clinic, Institut d Investigacio Biomedica August Pi i Sunyer IDIBAPS, University of Barcelona, Barcelona, Spain
    Nat Rev Nephrol 5:247-9. 2009
    ..The discovery that antibodies to a bacterial antigen can cross-react with a mammalian protein to cause pauci-immune necrotizing and crescentic glomerulonephritis opens up new possibilities for the diagnosis and treatment of this condition...
  27. doi request reprint Treatment of polymyalgia rheumatica: a systematic review
    José Hernández-Rodríguez
    Department of Internal Medicine, Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain
    Arch Intern Med 169:1839-50. 2009
    ..Our objective was to systematically examine the peer-reviewed literature on PMR therapy, particularly the optimal glucocorticoid type, starting doses, and subsequent reduction regimens as well as glucocorticoid-sparing medications...
  28. pmc Primary care referrals of patients with potentially serious diseases to the emergency department or a quick diagnosis unit: a cross-sectional retrospective study
    Xavier Bosch
    Department of Internal Medicine, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, University of Barcelona, Villarroel 170, Barcelona 08036, Spain
    BMC Fam Pract 15:75. 2014
    ..As a secondary objective, we determined the proportion of QDU patients who might have been evaluated in a less rapid, non-QDU setting...
  29. doi request reprint Prevalence, clinical characteristics and risk of myocardial infarction in patients with cocaine-related chest pain
    Xavier Bosch
    Servicio de Cardiologia, Institut del Tòrax, Hospital Clínic e Institut d Investigacions Biomèdiques August Pi i Sunyer IDIBAPS, Departamento de Medicina, Universidad de Barcelona, Barcelona, Spain
    Rev Esp Cardiol (Engl Ed) 63:1028-34. 2010
    ....
  30. doi request reprint [Systemic lupus erythematosus in the elderly]
    Xavier Bosch
    Unidad de Geriatria, Servicio de Medicina Interna, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Universidad de Barcelona, Barcelona, Spain
    Rev Esp Geriatr Gerontol 47:71-5. 2012
    ..In addition to the need for adopting a multidisciplinary approach, it is fundamental to obtain information about the functional, cognitive and social status of these patients in order to make appropriate healthcare decisions...
  31. pmc Outpatient Quick Diagnosis Units for the evaluation of suspected severe diseases: an observational, descriptive study
    Xavier Bosch
    Department of Internal Medicine, Hospital Clinic, Institut d Investigacio Biomedica August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    Clinics (Sao Paulo) 66:737-41. 2011
    ..Hospitals in countries with public health systems have recently adopted organizational changes to improve efficiency and resource allocation, and reducing inappropriate hospitalizations has been established as an important goal...
  32. doi request reprint [Prevalence of atrial fibrillation and related factors in hospitalized old patients: ESFINGE study]
    Alfonso Lopez Soto
    Servicio de Medicina Interna, Instituto Clínico de Medicina y Dermatología, Hospital Clinic de Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Universitat de Barcelona, Barcelona, Espana
    Med Clin (Barc) 138:231-7. 2012
    ..The main objective of this study was to assess the prevalence of AF in hospitalized old patients as well as its characteristics and related clinical and therapeutic factors...
  33. doi request reprint Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site
    Rafael Molina
    Laboratory of Clinical Biochemistry Unit for Cancer Research, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, University of Barcelona, Villarroel 170, Barcelona, 08036, Spain
    Tumour Biol 33:463-74. 2012
    ....
  34. doi request reprint The DWEYS peptide in systemic lupus erythematosus
    Xavier Bosch
    Department of Internal Medicine, Institut d Investigacions Biomediques August Pi i Sunyer, Hospital Clinic, University of Barcelona, Barcelona, Spain
    Trends Mol Med 18:215-23. 2012
    ..In this review, anti-dsDNA antibodies as a pathogenic factor in SLE and recent efforts for the creation of highly specific, nontoxic therapeutics against an extremely pathogenic subset of such antibodies is discussed...
  35. pmc B-cell-depleting therapy in systemic lupus erythematosus
    Manuel Ramos-Casals
    Laboratory of Autoimmune Diseases Josep Font, IDIBAPS, Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain
    Am J Med 125:327-36. 2012
    ....
  36. ncbi request reprint Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review
    Xavier Bosch
    Department of Internal Medicine, Hospital Clinic, Barcelona, Spain
    JAMA 298:655-69. 2007
    ..Long-term treatment and disease-related morbidity are major threats. The last decade has seen a collaborative international effort to determine effective treatment...
  37. doi request reprint Shoshin beriberi mimicking a high-risk non-ST-segment elevation acute coronary syndrome with cardiogenic shock: when the arteries are not guilty
    Pablo Loma-Osorio
    Unidad Coronaria, Servicio de Cardiologia, Hospital Clinic, Barcelona, Spain
    J Emerg Med 41:e73-7. 2011
    ..Cardiac acute beriberi (Shoshin syndrome) is a rare disease that may lead to a fatal outcome if not treated specifically...
  38. doi request reprint New insights in the management of cardiogenic shock complicating myocardial infarction: role of urgent heart transplantation
    Dabit Arzamendi
    Cardiology Unit, Cardio Thorax Institute Hospital Clinic de Barcelona, Barcelona, Spain
    J Heart Lung Transplant 27:984-9. 2008
    ..The primary end-point of the study was mortality at the 1-year follow-up...
  39. doi request reprint Monoclonal antibody therapy-associated neurological disorders
    Xavier Bosch
    Department of Internal Medicine, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain
    Nat Rev Neurol 7:165-72. 2011
    ....
  40. doi request reprint Therapy: Spleen tyrosine kinase inhibitors--novel therapies for RA?
    José A Gómez-Puerta
    Arthritis Unit, Department of Rheumatology, Hospital Clinic, Villarroel 170, Barcelona, Spain
    Nat Rev Rheumatol 7:134-6. 2011
    ..Where might these agents fit in the current armamentarium against this disease?..
  41. pmc Basophils, IgE, and autoantibody-mediated kidney disease
    Xavier Bosch
    Department of Internal Medicine, Hospital Clinic, Institut d Investigacions Bimoèdiques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain
    J Immunol 186:6083-90. 2011
    ..In addition to envisaging exciting therapeutic prospects, these novel findings open the way for the study of basophils in other autoimmune and renal diseases...
  42. doi request reprint Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes
    Xavier Bosch
    Department of Cardiology, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Villarroel 170, Barcelona, Spain, 08036
    Cochrane Database Syst Rev 10:CD002130. 2013
    ..Glycoprotein IIb/IIIa blockers strongly inhibit platelet aggregation and may prevent mortality and myocardial infarction. This is an update of a Cochrane review first published in 2001, and previously updated in 2007 and 2010...
  43. doi request reprint Financial, nonfinancial and editors' conflicts of interest in high-impact biomedical journals
    Xavier Bosch
    Department of Internal Medicine, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain
    Eur J Clin Invest 43:660-7. 2013
    ..To assess financial, nonfinancial and editors' conflicts of interest (COI) disclosure policies among the most influential biomedical journals publishing original research...
  44. doi request reprint Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis
    Ernesto Trallero-Araguás
    Vall d Hebron General Hospital, Barcelona, Spain
    Arthritis Rheum 64:523-32. 2012
    ..We performed a systematic review and meta-analysis to ascertain the accuracy of anti-p155 testing for the diagnosis of cancer-associated myositis...
  45. doi request reprint Therapeutic targeting of B cells for rheumatic autoimmune diseases
    Pablo Engel
    Immunology Unit, Department of Cell Biology, Immunology and Neuroscience, Faculty of Medicine, University of Barcelona, Barcelona, Spain
    Pharmacol Rev 63:127-56. 2011
    ....
  46. doi request reprint Prevention of chemotherapy-induced left ventricular dysfunction with enalapril and carvedilol: rationale and design of the OVERCOME trial
    Xavier Bosch
    Cardiology Department, Thorax Institute, Hospital Clinic, Barcelona, Spain
    J Card Fail 17:643-8. 2011
    ....
  47. doi request reprint Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance
    Ana García-Alvarez
    Thorax Clinic Institute, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
    Am J Cardiol 104:878-82. 2009
    ..The early determination of plasma BNP upon admission for STEMI could be helpful in identifying patients at higher risk for LV dilatation, in whom aggressive management is warranted...
  48. ncbi request reprint Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina
    Ignasi Anguera
    Institut de Malalties Cardiovasculars, Hospital Clinic, University of Barcelona, Barcelona, Spain
    Am Heart J 144:811-7. 2002
    ..The aims of this study were to determine the role of the anti-inflammatory cytokine interleukin (IL)-10 and the proinflammatory to anti-inflammatory ratios in the short-term prognosis of patients with unstable angina...
  49. ncbi request reprint Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute coronary syndromes
    Xavier Bosch
    Institut de Malalties Cardiovasculars, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain
    Am Heart J 150:215-20. 2005
    ..This study examines whether the routine determination of left ventricular ejection fraction (EF) adds significant prognostic information to currently recommended stratifiers...
  50. ncbi request reprint Prognostic value of clinical variables at presentation in patients with non-ST-segment elevation acute coronary syndromes: results of the Proyecto de Estudio del Pronóstico de la Angina (PEPA)
    Esteban Lopez de Sa
    Hospital General U Gregorio Marañón, Madrid, Spain
    Medicine (Baltimore) 81:434-42. 2002
    ....